SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice

Overview of attention for article published in Cardiovascular Diabetology, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 6 X users

patent: 1 patent

Citations

dimensions_citation: 113 Dimensions

Readers on

mendeley: 130 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 113 publications that cite this research output.

113

The most recent citing publications are shown below. View all 113 publications that cite this research output on Dimensions.

Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications

Article in Frontiers in Endocrinology (April 2024)

Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment

Article in Journal of Diabetes Investigation (March 2024)

Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry

Article in Journal of the American Heart Association (February 2024)